Max Robotics — Global Service Robot Directory + US Certification

About

Yu-Chih Chen is pioneering the integration of microfluidics, robotics, and artificial intelligence to transform single-cell analysis, with a particular focus on cancer cell migration and metastasis. His groundbreaking work addresses a critical gap in drug discovery—the tendency to overlook migration inhibitors in favor of cytotoxic compounds. Chen's most cited paper (2022, 25 citations) introduces a high-throughput platform for analyzing cellular heterogeneity in migration at the single-cell level, revealing how individual cancer cells behave differently within the same population. His subsequent work (2023, 10 citations) demonstrates how microfluidic chips can track large numbers of individual migrating cells, providing unprecedented insights into how extracellular matrices influence cell movement—a process essential to cancer metastasis, autoimmune diseases, and neurological disorders. Chen's forward-looking 2025 paper (8 citations) outlines a vision for transforming microfluidics through robotics and AI, enabling automated single-cell isolation and analysis that identifies rare subpopulations driving therapeutic resistance. His 2024 review (3 citations) synthesizes advances in linking phenotypes to genotypes at single-cell resolution. By combining engineering innovation with biological insight, Chen is creating tools that reveal the hidden heterogeneity within cellular populations, offering new pathways for understanding disease progression and developing targeted therapies.